Skip to main content
. Author manuscript; available in PMC: 2020 Mar 20.
Published in final edited form as: ACS Appl Mater Interfaces. 2019 Aug 5;11(32):28740–28751. doi: 10.1021/acsami.9b10379

Figure 7.

Figure 7.

Fabrication of multi-drug loaded bilayer composite meshes by using DRSNS-based setup and their antibacterial activity. (A) Schematic of multi-drug loaded bilayer composite meshes. Yellow layer: CUR loaded PLLA nanofibrous mesh; Blue layer DCS loaded PEO nanofibrous mesh. The morphology of each mesh was observed by SEM. Scale bar=5 μm; (B) Inhibition zone test for bilayer composite meshes without any drugs (a), with CUR alone (b), with DCS alone (c) and with both CUR and DCS (d) against S. aureus; (C) Average diameter calculation of inhibition zone of four different bilayer composite meshes.